These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23969300)

  • 1. Opioid and noradrenergic contributions of tapentadol in experimental neuropathic pain.
    Meske DS; Xie JY; Oyarzo J; Badghisi H; Ossipov MH; Porreca F
    Neurosci Lett; 2014 Mar; 562():91-6. PubMed ID: 23969300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-opioid and noradrenergic α(2)-adrenoceptor contributions to the effects of tapentadol on spinal electrophysiological measures of nociception in nerve-injured rats.
    Bee LA; Bannister K; Rahman W; Dickenson AH
    Pain; 2011 Jan; 152(1):131-139. PubMed ID: 21187272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on: Opioid and noradrenergic contributions of tapentadol in experimental neuropathic pain.
    Dickenson AH
    Neurosci Lett; 2014 Mar; 562():90. PubMed ID: 24121047
    [No Abstract]   [Full Text] [Related]  

  • 4. (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties.
    Tzschentke TM; Christoph T; Kögel B; Schiene K; Hennies HH; Englberger W; Haurand M; Jahnel U; Cremers TI; Friderichs E; De Vry J
    J Pharmacol Exp Ther; 2007 Oct; 323(1):265-76. PubMed ID: 17656655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain.
    Schröder W; Vry JD; Tzschentke TM; Jahnel U; Christoph T
    Eur J Pain; 2010 Sep; 14(8):814-21. PubMed ID: 20541444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic antihypersensitive effects of pregabalin and tapentadol in a rat model of neuropathic pain.
    Christoph T; De Vry J; Schiene K; Tallarida RJ; Tzschentke TM
    Eur J Pharmacol; 2011 Sep; 666(1-3):72-9. PubMed ID: 21640095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tapentadol: with two mechanisms of action in one molecule effective against nociceptive and neuropathic pain. Preclinical overview].
    Tzschentke TM; Christoph T; Schröder W; Englberger W; De Vry J; Jahnel U; Kögel BY
    Schmerz; 2011 Feb; 25(1):19-25. PubMed ID: 21258822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal-supraspinal and intrinsic μ-opioid receptor agonist-norepinephrine reuptake inhibitor (MOR-NRI) synergy of tapentadol in diabetic heat hyperalgesia in mice.
    Christoph T; Schröder W; Tallarida RJ; De Vry J; Tzschentke TM
    J Pharmacol Exp Ther; 2013 Dec; 347(3):794-801. PubMed ID: 24051022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of μ-opioid and noradrenaline reuptake inhibition in the modulation of pain responsive neurones in the central amygdala by tapentadol in rats with neuropathy.
    Gonçalves L; Friend LV; Dickenson AH
    Eur J Pharmacol; 2015 Feb; 749():151-60. PubMed ID: 25576174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tapentadol increases levels of noradrenaline in the rat spinal cord as measured by in vivo microdialysis.
    Tzschentke TM; Folgering JH; Flik G; De Vry J
    Neurosci Lett; 2012 Jan; 507(2):151-5. PubMed ID: 22197547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation.
    Gardell LR; Vanderah TW; Gardell SE; Wang R; Ossipov MH; Lai J; Porreca F
    J Neurosci; 2003 Sep; 23(23):8370-9. PubMed ID: 12967999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated Administration of Duloxetine Suppresses Neuropathic Pain by Accumulating Effects of Noradrenaline in the Spinal Cord.
    Ito S; Suto T; Saito S; Obata H
    Anesth Analg; 2018 Jan; 126(1):298-307. PubMed ID: 28787337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated Administration of Amitriptyline in Neuropathic Pain: Modulation of the Noradrenergic Descending Inhibitory System.
    Hiroki T; Suto T; Saito S; Obata H
    Anesth Analg; 2017 Oct; 125(4):1281-1288. PubMed ID: 28787345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual μ-opioid receptor and norepinephrine reuptake mechanisms contribute to dezocine- and tapentadol-induced mechanical antiallodynia in cancer pain.
    Mao XF; Ahsan MZ; Apryani E; Tang XQ; Zhao MJ; Li XY; Wang YX
    Eur J Pharmacol; 2020 Jun; 876():173062. PubMed ID: 32173379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.
    Largent-Milnes TM; Guo W; Wang HY; Burns LH; Vanderah TW
    J Pain; 2008 Aug; 9(8):700-13. PubMed ID: 18468954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tapentadol on mechanical hypersensitivity in rats with ligatures of the infraorbital nerve versus the sciatic nerve.
    Michot B; Bourgoin S; Kayser V; Hamon M
    Eur J Pain; 2013 Jul; 17(6):867-80. PubMed ID: 23229959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological evaluation of the selective spinal nerve ligation model of neuropathic pain in the rat.
    LaBuda CJ; Little PJ
    J Neurosci Methods; 2005 Jun; 144(2):175-81. PubMed ID: 15910975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine-induced depression of spinal excitation is not altered following acute disruption of GABA(A) or GABA(B) receptor activity.
    Buesa I; Urrutia A; Bilbao J; Aguilera L; Zimmermann M; Azkue JJ
    Eur J Pain; 2008 Aug; 12(6):677-85. PubMed ID: 18551744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats.
    Wegert S; Ossipov MH; Nichols ML; Bian D; Vanderah TW; Malan TP; Porreca F
    Pain; 1997 May; 71(1):57-64. PubMed ID: 9200174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents.
    Jones CK; Peters SC; Shannon HE
    J Pharmacol Exp Ther; 2005 Feb; 312(2):726-32. PubMed ID: 15494550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.